Chemomab Therapeutics Ltd
NASDAQ:CMMB
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Price:
1.57
USD
-4.27%
Market Cap:
$8.3m
Balance Sheet
Balance Sheet Decomposition
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd
Balance Sheet Decomposition is not available for
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd
Balance Sheet
Chemomab Therapeutics Ltd
Chemomab Therapeutics Ltd
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
12
|
15
|
14
|
9
|
6
|
|
| Cash Equivalents |
12
|
15
|
14
|
9
|
6
|
|
| Short-Term Investments |
0
|
46
|
26
|
10
|
8
|
|
| Other Current Assets |
0
|
2
|
2
|
1
|
2
|
|
| Total Current Assets |
12
|
63
|
42
|
21
|
16
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
1
|
0
|
|
| Total Assets |
12
N/A
|
64
+416%
|
43
-33%
|
22
-49%
|
17
-23%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
1
|
2
|
1
|
1
|
|
| Accrued Liabilities |
1
|
1
|
5
|
4
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
3
|
7
|
5
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+73%
|
7
+137%
|
5
-25%
|
3
-34%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
24
|
36
|
64
|
89
|
103
|
|
| Additional Paid In Capital |
35
|
98
|
101
|
106
|
116
|
|
| Treasury Stock |
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
11
N/A
|
61
+469%
|
36
-41%
|
17
-53%
|
14
-20%
|
|
| Total Liabilities & Equity |
12
N/A
|
64
+416%
|
43
-33%
|
22
-49%
|
17
-23%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
0
|
4
|
4
|
4
|
94
|
|
Switch to:
Switch to:
See Also
Discover More
